Trials / Unknown
UnknownNCT06173882
Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis
The Therapeutic Effect and Standardization of Moxibustion in the Treatment of Allergic Rhinitis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Henan University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are: Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis
Detailed description
Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Ordinary moxibustion volume group | Moxibustion for 10 minutes per acupoint |
| BEHAVIORAL | First group of heavy moxibustion | Moxibustion for 20 minutes per acupoint |
| BEHAVIORAL | Second groups of heavy moxibustion | Moxibustion for 30 minutes per acupoint |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2024-08-01
- Completion
- 2025-08-01
- First posted
- 2023-12-18
- Last updated
- 2023-12-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06173882. Inclusion in this directory is not an endorsement.